Health Condition 1: K069- Disorder of gingiva and edentulousalveolar ridge, unspecified
Conditions
Interventions
Intervention1: Guided Implant Surgery: The implant sites were prepared according to the manufacturerâ??s guidelines using a DIOnavi concept i.e. digital navigation implant surgery through 3D computer
Sponsors
DR PSG PRAKASH
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients with age ranging from 19 -50 years. 2)Patients not contraindicated for periodontal surgical procedures. 3)Patients who have given written and verbal informed consent for the study. 4)Isolated edentulous sites from Maxillary anteriors and premolars with single rooted edentulous sites were taken for the study. 5)The choice of patient selection for socket Augmented group are the patients with a previous history of extraction followed by socket augmentation with Bio active synthetic glass bone graft and left to heal for a minimum of six months at the time of evaluation. 6)The choice of patient selection for Non Augmented group are , the patients with a history of previous extraction followed by spontaneous healing for a minimum of 6 months at the time of evaluation. 7)The patients who presented with a single edentulous site having a minimum bone height >= 9mm and bone width >= 4mm evaluated through CBCT bounded on either side by healthy natural teeth.
Exclusion criteria
Exclusion criteria: 1)Chronic therapy under non-steroidal anti-inflammatory drugs, Bisphosphonates and Corticosteroids. 2)Current smokers ( >10 cigarettes per day). 3)Evidence of loss of any bony wall at the time of extraction or during socket augmentation. 4)The extractions other than the following reasons will be excluded: •Extraction of teeth due to Failure of endodontic treatment. •Extraction due to Fracture of tooth due to trauma and the fracture line extending subgingivally which cannot be restored endodontically. •Tooth with poor prognosis (grossly decayed). •Residual root stumps. 5)Pregnancy. 6)Untreated periodontitis. 7)Para-functional habits. 8)Immunosuppressed or immunocompromised patients. 9)Active infection or severe inflammation at the implant placement site.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Mean Crestal bone level measurements to be assessed at 1 year with standardized radiographs. 2.Implant survival rates to be assessed at 1 year with radiographic and clinical assessment. Timepoint: 1.Mean Crestal bone level measurements to be assessed at 1 year with standardized radiographs. 2.Implant survival rates to be assessed at 1 year with radiographic and clinical assessment. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To assess Pain, Discomfort, Swelling and Interference with daily activities using 10cm Visual Analogue Scale at 1 week post operatively.Timepoint: one week | — |
Countries
India
Contacts
Public ContactDR PRIYANKAB
SRM DENTAL COLLEGE
Outcome results
None listed